• Genmab average return on equity for 2023 was 16.79, a 7.19% decline from 2022.
• Genmab average return on equity for 2022 was 18.09, a 0.28% decline from 2021.
• Genmab average return on equity for 2021 was 18.04, a 39.75% increase from 2020.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.